Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2025-05-08 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
114年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 科妍, reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements, management discussion, or audit information. The content is concise and factual, typical of a regulatory compliance disclosure rather than a full report. Given the short length (601 characters) and the nature of the data, this fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-05-08 Chinese
114年4月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 科妍, presented in New Taiwan Dollars. It includes percentage changes compared to the previous year and explanatory notes about accounting standards and reporting practices. The document is very short (763 characters) and does not contain detailed financial statements or comprehensive analysis. It appears to be a brief financial summary or factsheet rather than a full financial report or announcement. There is no indication of it being an earnings release, annual or interim report, or any regulatory filing. Given the brevity and nature of the content, the best fitting category is Fund Information / Factsheet (FS), which covers brief summaries of key company financials and market info.
2025-05-08 Chinese
114年第1季權益變動表
Interim / Quarterly Report Classification · 90% confidence The document contains detailed tables of equity changes, including items such as common stock capital, capital surplus, retained earnings, and other equity components for specific fiscal periods (e.g., Q1 of year 114 and 113 in the Taiwanese calendar). The presence of detailed financial data related to equity changes and comprehensive accounting items indicates this is a financial report rather than a brief announcement or certification. The document length is 3739 characters, which is relatively short but contains substantive financial data. The content aligns with a quarterly or interim financial report, as it covers a specific quarter's equity changes and financial figures. There is no indication that this is an announcement of a report or a certification letter. Therefore, the document is best classified as an Interim / Quarterly Report (IR). Q1 2025
2025-05-08 Chinese
114年第1季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the first quarter of the 114th year (which corresponds to 2025) and compares it with the same period in the previous year. It includes detailed financial data such as net profit before tax, depreciation, amortization, changes in assets and liabilities, and cash flows from operating, investing, and financing activities. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 2073 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2025
2025-05-08 Chinese
114年第1季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the first quarter of the 114th year (which corresponds to 2025) with detailed financial figures such as revenue, costs, expenses, and net income. The presence of actual financial data for a quarterly period indicates this is a substantive financial report for a period shorter than a full fiscal year. The document length is 1985 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2025
2025-05-08 Chinese
114年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items with amounts and percentages. The data is presented for the first quarter of the year 114 (Taiwan calendar, corresponding to 2025) and prior periods. The document is 3872 characters long, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. The presence of detailed financial statements for a quarterly period indicates this is an Interim / Quarterly Report (IR). There is no indication that this is an annual report, audit report, or other types of filings. The document is not a mere announcement or certification, so it is not RPA or RNS. Therefore, the best classification is IR (Interim / Quarterly Report). Q1 2025
2025-05-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.